Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
03/23/20163:32PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
03/15/20166:00AMGlobeNewswire Inc.Summit Announces Publication on Biomarkers to Quantify Utrophin Protein and Regeneration of Muscle Fibres in DMDNASDAQ:SMMTSummit Therapeutics Inc
03/09/20166:46PMGlobeNewswire Inc.Summit Announces Ridinilazole Preserves the Gut Microbiome of Patients With C. difficile Infection in Phase 2 TrialNASDAQ:SMMTSummit Therapeutics Inc
03/09/20166:46PMGlobeNewswire Inc.Summit Therapeutics Supports Ninth Annual Rare Disease DayNASDAQ:SMMTSummit Therapeutics Inc
03/09/20166:46PMGlobeNewswire Inc.Summit Therapeutics Announces Publication of Preclinical Data Showing Ridinilazole Outperformed Standard of Care in Reducing ...NASDAQ:SMMTSummit Therapeutics Inc
03/07/20163:17PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
02/17/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in SunTrust Robinson Humphrey’s 2016 Orphan Drug DayNASDAQ:SMMTSummit Therapeutics Inc
02/16/201612:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMMTSummit Therapeutics Inc
02/03/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Present at 18th Annual BIO CEO & Investor ConferenceNASDAQ:SMMTSummit Therapeutics Inc
01/22/20163:24PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
01/21/20166:00AMGlobeNewswire Inc.Summit Therapeutics Receives Regulatory Approval to Initiate PhaseOut DMD, a Phase 2 Clinical Trial of SMT C1100 in Patients ...NASDAQ:SMMTSummit Therapeutics Inc
01/19/20166:00AMGlobeNewswire Inc.Summit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
12/17/20154:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
12/17/20156:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
12/14/20156:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Third Quarter Ended 31 October 2015 on 17 December 2015NASDAQ:SMMTSummit Therapeutics Inc
12/10/20156:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in the JMP Securities DMD ForumNASDAQ:SMMTSummit Therapeutics Inc
12/03/20156:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the 26th Annual Oppenheimer Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
12/02/20154:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
12/02/20156:00AMGlobeNewswire Inc.Summit Therapeutics Announces First Milestone Achieved in Strategic Alliance With University of Oxford for Future Generation ...NASDAQ:SMMTSummit Therapeutics Inc
11/25/20156:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Piper Jaffray 27th Annual Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
11/23/20153:15PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/23/20156:00AMGlobeNewswire Inc.Summit Therapeutics Announces Novel Antibiotic Ridinilazole (SMT19969) Achieves Statistical Superiority Over Vancomycin in Co...NASDAQ:SMMTSummit Therapeutics Inc
11/20/20153:25PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/17/20156:00AMGlobeNewswire Inc.Summit Therapeutics and the University of Oxford Announce Multi-Year Extension of Strategic Alliance for Development of Utrop...NASDAQ:SMMTSummit Therapeutics Inc
10/01/20153:56PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/30/20156:00AMGlobeNewswire Inc.Summit Therapeutics Presents Additional Data From Phase 1b Modified Diet Clinical Trial of SMT C1100 in DMD Patients at WMSNASDAQ:SMMTSummit Therapeutics Inc
09/24/20156:00AMGlobeNewswire Inc.Summit Therapeutics to Present Phase 1b Clinical and Preclinical DMD Data at the 20th International Congress of the World Mus...NASDAQ:SMMTSummit Therapeutics Inc
09/21/20157:46PMGlobeNewswire Inc.Summit Therapeutics Completes Targeted Enrolment for SMT19969 Phase 2 Trial for C. difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
09/14/20153:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/03/20153:02PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT